Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Nanobac Pharmaceuticals Inc (CE) (NNBP)
Nanobac Pharmaceuticals Inc (CE) (NNBP) Actualités

NNBP

Nanobac Pharmaceuticals (CE) (NNBP)

Nanobac Pharmaceuticals Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:NNBP

1

Date	Heure	Source	Titre	Symbole	Société
20/05/2011	20h12	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 12(g) (15-12G)	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
23/04/2009	15h45	Marketwired	Nanobac Pharmaceuticals Merger Partner, Eureka Genomics, and Glycos Biotechnologies Work Together to Sequence Proprietary Bacter	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
21/04/2009	15h45	Marketwired	Nanobac Pharmaceuticals Merger Partner Eureka to Utilize Best-In-Class Illumina Genome Analyzer Technology at Newly Launched Eur	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
13/04/2009	16h42	Marketwired	Nanobac Pharmaceuticals and Eureka Genomics Sign Merger Agreement	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
17/03/2009	14h45	Marketwired	Nanobac Pharmaceuticals and Eureka Genomics Agree to Terms for Merger	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
27/02/2009	21h30	Marketwired	Nanobac Message to Shareholders	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
15/04/2008	23h14	Edgar (US Regulatory)	Nanobac Pharmaceuticals Inc - Annual Report (Small Business Issuers) (10KSB)	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
08/04/2008	17h06	Marketwired	Nanobac Announces Peer Reviewed Publication Verifying Self-Propagating Calcifying Nanoparticles as a Unique Entity	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
08/04/2008	15h45	Marketwired	Nanobac Announces Mayo Clinic Researchers Audio Interview	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
31/03/2008	22h31	Edgar (US Regulatory)	Nanobac Pharmaceuticals Inc - Notification that Annual Report will be submitted late (NT 10-K)	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
25/03/2008	14h46	Marketwired	Nanobac Pharmaceuticals, Inc. Announces Collaboration Agreement With BioChemics for Transdermal Therapeutic Formulation	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
19/02/2008	19h44	Marketwired	Nanobac Announces Study Results of Association of Nanoparticle and Kidney Stone Formation	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
19/02/2008	17h27	Marketwired	Nanobac Announces Publication of Association of Nanoparticle and Kidney Stone Formation	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
05/12/2007	16h23	Edgar (US Regulatory)	Nanobac Pharmaceuticals Inc - Amended Current report filing (8-K/A)	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
20/11/2007	20h25	Edgar (US Regulatory)	Nanobac Pharmaceuticals Inc - Amended Quarterly Report of Financial Condition (10QSB/A)	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
19/11/2007	23h17	Edgar (US Regulatory)	Nanobac Pharmaceuticals Inc - Quarterly Report of Financial Condition (10QSB)	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
14/11/2007	19h50	Edgar (US Regulatory)	Nanobac Pharmaceuticals Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)
15/10/2007	16h48	Edgar (US Regulatory)	Nanobac Pharmaceuticals Inc - Current report filing (8-K)	USOTC:NNBP	Nanobac Pharmaceuticals Inc (CE)

Showing the most relevant articles for your search:USOTC:NNBP

1

Societe Generale

Cie de SaintGobain

Lvmh Moet Hennessy Louis...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales